138 related articles for article (PubMed ID: 20039175)
21. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.
Mendenhall WM; Amdur RJ; Morris CG; Kirwan JM; Li JG
Laryngoscope; 2010 Nov; 120(11):2218-22. PubMed ID: 20938964
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
23. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
[TBL] [Abstract][Full Text] [Related]
24. Impact of Expression of CD44, a Cancer Stem Cell Marker, on the Treatment Outcomes of Intensity Modulated Radiation Therapy in Patients With Oropharyngeal Squamous Cell Carcinoma.
Motegi A; Fujii S; Zenda S; Arahira S; Tahara M; Hayashi R; Akimoto T
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):461-8. PubMed ID: 26867875
[TBL] [Abstract][Full Text] [Related]
25. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
[TBL] [Abstract][Full Text] [Related]
26. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes.
Choby GW; Kim J; Ling DC; Abberbock S; Mandal R; Kim S; Ferris RL; Duvvuri U
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):499-504. PubMed ID: 25834991
[TBL] [Abstract][Full Text] [Related]
27. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
[TBL] [Abstract][Full Text] [Related]
28. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.
Huang K; Xia P; Chuang C; Weinberg V; Glastonbury CM; Eisele DW; Lee NY; Yom SS; Phillips TL; Quivey JM
Cancer; 2008 Aug; 113(3):497-507. PubMed ID: 18521908
[TBL] [Abstract][Full Text] [Related]
29. Quality of life in oropharyngeal cancer: a structured review of the literature.
Roets E; Tukanova K; Govarts A; Specenier P
Support Care Cancer; 2018 Aug; 26(8):2511-2518. PubMed ID: 29725802
[TBL] [Abstract][Full Text] [Related]
30. Correlation between plan quality improvements and reduced acute dysphagia and xerostomia in the definitive treatment of oropharyngeal squamous cell carcinoma.
Cui T; Ward MC; Joshi NP; Woody NM; Murray EJ; Potter J; Dorfmeyer AA; Greskovich JF; Koyfman SA; Xia P
Head Neck; 2019 Apr; 41(4):1096-1103. PubMed ID: 30702180
[TBL] [Abstract][Full Text] [Related]
31. Quality-of-life scores compared to objective measures of swallowing after oropharyngeal chemoradiation.
Kendall KA; Kosek SR; Tanner K
Laryngoscope; 2014 Mar; 124(3):682-7. PubMed ID: 23929736
[TBL] [Abstract][Full Text] [Related]
32. Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma.
May JT; Rao N; Sabater RD; Boutrid H; Caudell JJ; Merchant F; Han G; Padhya TA; McCaffrey JC; Tanvetyanon T; Deconti R; Kish J; McCaffrey TV; Trotti A
Head Neck; 2013 Dec; 35(12):1796-800. PubMed ID: 23468387
[TBL] [Abstract][Full Text] [Related]
33. Quality of life of disease-free survivors of advanced (stage III or IV) oropharyngeal cancer.
Deleyiannis FW; Weymuller EA; Coltrera MD
Head Neck; 1997 Sep; 19(6):466-73. PubMed ID: 9278753
[TBL] [Abstract][Full Text] [Related]
34. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).
Eisbruch A; Harris J; Garden AS; Chao CK; Straube W; Harari PM; Sanguineti G; Jones CU; Bosch WR; Ang KK
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1333-8. PubMed ID: 19540060
[TBL] [Abstract][Full Text] [Related]
35. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
36. Treatment outcomes of locally advanced oropharyngeal cancer: a comparison between combined modality radio-chemotherapy and two variants of single modality altered fractionation radiotherapy.
Kader HA; Mydin AR; Wilson M; Alexander C; Shahi J; Pathak I; Wu JS; Truong PT
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1030-6. PubMed ID: 20675071
[TBL] [Abstract][Full Text] [Related]
37. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
Dirix P; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
[TBL] [Abstract][Full Text] [Related]
38. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain.
Thomas L; Jones TM; Tandon S; Carding P; Lowe D; Rogers S
Clin Otolaryngol; 2009 Feb; 34(1):34-42. PubMed ID: 19260883
[TBL] [Abstract][Full Text] [Related]
39. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
40. Screening for dysfunction to promote multidisciplinary intervention by using the University of Washington Quality of Life Questionnaire.
Rogers SN; Lowe D
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):369-75. PubMed ID: 19380359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
